The glittering world of Bollywood often feels like it operates in a vacuum, a place where stardust and screen presence shield icons from the mundane realities of regulatory compliance. However, in recent weeks, the air in Mumbai’s corporate and celebrity circles has shifted. The Maharashtra Food and Drug Administration (FDA) has leveled a serious challenge against three of the biggest names in Indian cinema—Shah Rukh Khan, Ajay Devgn, and Tiger Shroff—bringing the contentious issue of “surrogate advertising” into the harsh light of a legal inquiry.
Tukaram Mundhe, the Commissioner of the Maharashtra FDA, recently confirmed that the trio has officially responded to the show-cause notices issued to them regarding their association with the Vimal Elaichi brand. With two of the actors having already completed their formal hearings, the message from the regulatory body is clear: the era of celebrities being untouchable brand ambassadors may be coming to a definitive end.
## The Crackdown on Surrogate Advertising
At the heart of this controversy lies the thin, often transparent veil of “surrogate advertising.” Under Indian law, the advertising of tobacco and pan masala products is strictly prohibited. To bypass these restrictions, manufacturers often launch a “brand extension”—a product like cardamom (elaichi) or mouth freshener—that carries the same brand name and aesthetic as their restricted tobacco-based line.
The FDA’s stance is that this is a classic “bait and switch” designed to maintain brand recall for the banned substances. By serving show-cause notices to Khan, Devgn, and Shroff, the Maharashtra regulator is not merely slapping wrists; they are aggressively targeting the faces behind the campaign. They have demanded comprehensive documentation, including original contracts, campaign briefs, and proof of the “due diligence” the actors supposedly performed before signing on the dotted line.
## Leveraging the Food Safety and Standards Act
The FDA’s legal arsenal is anchored in the Food Safety and Standards Act (FSSA) of 2006. Specifically, they are invoking Section 24, which addresses misleading and deceptive food advertisements, and Section 53, which carries a financial penalty of up to ₹10 lakh for those responsible for publishing such advertisements.
Mundhe has been vocal about the fact that celebrities cannot simply plead ignorance or pass the buck to the manufacturers. The regulatory shift is prioritizing the responsibility of the endorser. In the eyes of the law, if a superstar with a massive public following lends their voice and persona to a brand, they are effectively vouching for the safety and legitimacy of the product. The FDA’s move is intended to establish a precedent: the “I just signed the contract” defense is no longer a valid shield against legal accountability.
## The Star Power Dilemma
The roster of actors involved highlights the scale of this issue. Ajay Devgn has long been the face of the Vimal campaign, his presence becoming synonymous with the brand’s ubiquitous television spots. Shah Rukh Khan, the industry’s biggest global draw, joined the campaign, raising eyebrows among fans and critics alike. Tiger Shroff joined the fray more recently, filling a vacancy left by Akshay Kumar.
Akshay Kumar’s own exit from the brand serves as a cautionary tale of the power of public sentiment. After intense social media backlash in 2022, Kumar issued a public apology, stepped down from the endorsement, and pledged to donate his fees. It was a rare instance of a high-profile exit, but it also underscored the tension between financial gain and public responsibility. For Khan, Devgn, and Shroff, the choice is now far more complicated than a simple PR pivot; they are now embroiled in a state-led investigation that challenges the very nature of their commercial ventures.
## The “Elaichi vs. Tobacco” Argument
In past interviews, the actors have attempted to distance themselves from the controversy. Ajay Devgn has consistently maintained that his contract—and his moral obligation—is strictly tied to the promotion of elaichi (cardamom), not the restricted pan masala products.
Shah Rukh Khan has articulated a broader, albeit controversial, perspective on the matter. The superstar has previously suggested that if a product is truly harmful to society, the responsibility should lie with the government to halt its manufacture and sale entirely, rather than placing the burden of societal health on the shoulders of actors. He argues that as long as the government allows the sale of a product, there is an inherent contradiction in punishing individuals for promoting it. However, the FDA’s current pursuit suggests they are tired of hearing this circular logic and are determined to dismantle the platform that allows these products to thrive in the public consciousness.
## What Lies Ahead
As the hearings conclude and the FDA continues its review, the industry is holding its breath. The outcome of this case could set a massive precedent for the future of celebrity endorsements in India. If the Maharashtra FDA succeeds in penalizing these high-profile figures, it could lead to a massive migration of celebrities away from “brand extension” marketing tactics.
The investigation is a wake-up call for the talent agencies and legal teams that represent India’s elite. The days of signing multi-crore deals without deep-diving into the broader implications of a brand’s business model are under threat. For the actors involved, this is no longer just about maintaining their “clean” images; it’s about navigating a regulatory climate that is becoming increasingly intolerant of the games companies play to keep their products on the screen.
Whether or not the FDA succeeds in imposing significant penalties, the “Vimal Case” has already shifted the discourse. The public is watching, the regulators are moving, and the stars are being forced to defend their choices. As Tukaram Mundhe noted, the matter is proceeding—and for the celebrity landscape, the implications may linger long after the final verdict is delivered.
Disclaimer: This content is auto-generated for informational purposes only.
Source: Read Original News
